Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000429185 | SCV000510682 | likely benign | not provided | 2016-09-23 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV000362161 | SCV000636603 | benign | Kleefstra syndrome 1 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313877 | SCV000849032 | benign | Inborn genetic diseases | 2016-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000429185 | SCV001837417 | benign | not provided | 2019-09-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000429185 | SCV005224865 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116963 | SCV000151079 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Prevention |
RCV003905114 | SCV004720287 | benign | EHMT1-related disorder | 2019-04-04 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |